If you’re on the fence about investing in CRISPR Therapeutics AG, Grifols or S.A. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Spanish plasma-based medicines maker Grifols (MCE: GRF) has announced disappointing top-line data from its Phase III PRECIOSA clinical trial evaluating the potential of long-term albumin treatment ...
US short seller Gotham City Research asked a judge in New York to dismiss a lawsuit accusing it of conspiring to drive down shares in Grifols SA. The drug maker’s market capitalization has ...
Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC. Grifols acquired the Johnston County facility in 2011 ...
Mayor Ken Hopkins and the city of Cranston welcomed Grifols Biomat USA, located in the Cranston Parkade Shopping Center 300 Garfield Ave., to the community with a recent ribbon-cutting ceremony. The ...
Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, is adding 300 more to its Clayton workforce as part of a $351.6 million expansion there. Gov. Roy Cooper ...